(Q43955981)

28 November 2017

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers (English)

1 reference

28 November 2017

3

Yasushi Yatabe

1 reference

28 November 2017

Hirotaka Osada

1

1 reference

28 November 2017

Yoshio Tatematsu

2

1 reference

28 November 2017

Taku Nakagawa

4

1 reference

28 November 2017

Hiroyuki Konishi

5

1 reference

28 November 2017

Tomoko Harano

6

1 reference

28 November 2017

Ekmel Tezel

7

1 reference

28 November 2017

Minoru Takada

8

1 reference

28 November 2017

Takashi Takahashi

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

21

1 reference

28 November 2017

2418-2424

1 reference

28 November 2017

15

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205303

28 November 2017

0 references

cites work

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

High sensitivity mapping of methylated cytosines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Subcellular localization and protein interaction of the human LIMK2 gene expressing alternative transcripts with tissue-specific regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Progress in understanding the molecular pathogenesis of human lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205303

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205303

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference